Lipotek is a company dedicated to developing versatile antigen delivery modules that facilitate dendritic cell (DC) targeting and activation in vivo. Its approach to vaccine design is, therefore, to ensure that antigens are delivered to DCs, with simultaneous activation of DCs using cytokines and/or Toll-like receptor (TLR) ligands.